4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-16-156175
President and CEO gave up 889 shares (to pay taxes)
- President and CEO acquired 2,925 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal President and CEO | 2016-12-18 | Option exercise | +2,925 | 874,908 | D: show line 1 in the form | ||
| Walker Neal President and CEO | 2016-12-18 | Shares withheld for taxes | −889 | $31.25 | $27,781 | 874,019 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Walker Neal President and CEO | 2016-12-18 | Option exercise · Restricted Stock Units | −2,925 | 8,775 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…